The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH)
Aim: Prostate artery embolization (PAE) is a non invasive modality for the treatment of benign prostate hypertrophy (BPH) related lower urinary tract symptoms (LUTS). As a relatively new procedure, data determining the clinical success is somehow scarce. In the present article we examine the current...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2018-03-01
|
Series: | Archivio Italiano di Urologia e Andrologia |
Subjects: | |
Online Access: | http://www.pagepressjournals.org/index.php/aiua/article/view/7067 |
id |
doaj-7a435038d9494fb89bd5d72010dbaf60 |
---|---|
record_format |
Article |
spelling |
doaj-7a435038d9494fb89bd5d72010dbaf602020-11-25T02:05:28ZengPAGEPress PublicationsArchivio Italiano di Urologia e Andrologia1124-35622282-41972018-03-01901404310.4081/aiua.2018.1.405643The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH)Konstantinos Stamatiou0Urology Department, Tzaneio Hospital, PiraeusAim: Prostate artery embolization (PAE) is a non invasive modality for the treatment of benign prostate hypertrophy (BPH) related lower urinary tract symptoms (LUTS). As a relatively new procedure, data determining the clinical success is somehow scarce. In the present article we examine the current clinical outcome measures in order to identify the most accurate. Results: Current imaging outcome measures are consistent with clinical ones only in the group of patients with adenomatous- dominant BPH while are inconsistent in patients with small sized adenomas. Conclusions: Additional studies and/or evaluation tools are needed in order to provide accurate evaluation of clinical success in the subgroup of patients with non- adenomatous-dominant BPH while they may inspire new options and novel techniques for both BPH treatment and treatment-follow up.http://www.pagepressjournals.org/index.php/aiua/article/view/7067Benign prostatic hyperplasiaLower urinary tract symptomsProstate artery embolization |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Konstantinos Stamatiou |
spellingShingle |
Konstantinos Stamatiou The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH) Archivio Italiano di Urologia e Andrologia Benign prostatic hyperplasia Lower urinary tract symptoms Prostate artery embolization |
author_facet |
Konstantinos Stamatiou |
author_sort |
Konstantinos Stamatiou |
title |
The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH) |
title_short |
The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH) |
title_full |
The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH) |
title_fullStr |
The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH) |
title_full_unstemmed |
The impact of prostate artery embolization (PAE) on the the physical history and pathophysiology of benign prostatic hyperplasia (BPH) |
title_sort |
impact of prostate artery embolization (pae) on the the physical history and pathophysiology of benign prostatic hyperplasia (bph) |
publisher |
PAGEPress Publications |
series |
Archivio Italiano di Urologia e Andrologia |
issn |
1124-3562 2282-4197 |
publishDate |
2018-03-01 |
description |
Aim: Prostate artery embolization (PAE) is a non invasive modality for the treatment of benign prostate hypertrophy (BPH) related lower urinary tract symptoms (LUTS). As a relatively new procedure, data determining the clinical success is somehow scarce. In the present article we examine the current clinical outcome measures in order to identify the most accurate.
Results: Current imaging outcome measures are consistent with clinical ones only in the group of patients with adenomatous- dominant BPH while are inconsistent in patients with small sized adenomas.
Conclusions: Additional studies and/or evaluation tools are needed in order to provide accurate evaluation of clinical success in the subgroup of patients with non- adenomatous-dominant BPH while they may inspire new options and novel techniques for both BPH treatment and treatment-follow up. |
topic |
Benign prostatic hyperplasia Lower urinary tract symptoms Prostate artery embolization |
url |
http://www.pagepressjournals.org/index.php/aiua/article/view/7067 |
work_keys_str_mv |
AT konstantinosstamatiou theimpactofprostatearteryembolizationpaeonthethephysicalhistoryandpathophysiologyofbenignprostatichyperplasiabph AT konstantinosstamatiou impactofprostatearteryembolizationpaeonthethephysicalhistoryandpathophysiologyofbenignprostatichyperplasiabph |
_version_ |
1724937745322737664 |